Exchange Traded Concepts’s Harmony Biosciences HRMY Stock Holding History

Exchange Traded Concepts’s Portfolio HRMY Stock Details HRMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.75M	Sell	44,539 -43,352	-49%	-$1.68M	0.01%	796
2026 Q2	$3.2M	Buy	87,891 +879	+1%	+$27.7K	0.01%	577
2026 Q1	$2.44M	Buy	87,012 +29,539	+51%	+$969K	0.02%	557
2025 Q4	$2.15M	Sell	57,473 -7,550	-12%	-$248K	0.02%	579
2025 Q3	$1.79M	Buy	65,023 +32,923	+103%	+$1.13M	0.02%	602
2025 Q2	$1.01M	Buy	32,100 +1,844	+6%	+$59.3K	0.01%	678
2025 Q1	$1M	Buy	+30,256	New	+$1.08M	0.02%	560
2024 Q3	–	Sell	-28,393	Closed	-$857K	–	1370
2024 Q2	$857K	Buy	28,393 +1,668	+6%	+$50.2K	0.02%	489
2024 Q1	$897K	Sell	26,725 -14,164	-35%	-$455K	0.02%	460
2023 Q4	$1.32M	Buy	40,889 +328	+0.8%	+$9.16K	0.04%	340
2023 Q3	$1.33M	Buy	40,561 +40,163	+10,091%	+$1.39M	0.04%	308
2023 Q2	$14K	Sell	398 -7	-2%	-$242	﹤0.01%	1187
2023 Q1	$13.2K	Buy	+405	New	+$18.4K	﹤0.01%	994

Other funds holding HRMY

CX Institutional Auburn, Indiana $3.69B AUM 15.82% 1-Year Est. Return

Wedge Capital Management Charlotte, North Carolina $5.72B AUM 38.26% 1-Year Est. Return

Sidoxia Capital Management Newport Beach, California $142M AUM

Virginia Retirement Systems Richmond, Virginia $16.3B AUM 35.33% 1-Year Est. Return

CWA Asset Management Group Naples, Florida $3.39B AUM 25.16% 1-Year Est. Return

Pavaki Capital Management Pueblo, Colorado $294M AUM 34.46% 1-Year Est. Return

Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return

Hedeker Wealth Lincolnshire, Illinois $545M AUM 27.48% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return

Exchange Traded Concepts's HRMY Position: Q3 2026 in Review

Exchange Traded Concepts reduced its Harmony Biosciences (HRMY) stake by 49% in Q3 2026, selling an estimated $1.68M and leaving 44,539 shares worth $1.75M. The position accounts for 0.01% of the portfolio, ranked #796.

Exchange Traded Concepts first reported a position in HRMY in Q1 2023 and has held it in 13 quarters since. The position peaked at $3.2M in Q2 2026. 75 funds tracked by Wall St. Rank hold HRMY as of Q3 2026.

Exchange Traded Concepts held 44,539 shares of Harmony Biosciences worth $1.75M as of Q3 2026.
Exchange Traded Concepts sold 43,352 Harmony Biosciences shares in Q3 2026, an estimated $1.68M.
Harmony Biosciences made up 0.01% of Exchange Traded Concepts's portfolio in Q3 2026, its #796 holding.
Exchange Traded Concepts first reported a position in Harmony Biosciences in Q1 2023 and has held it in 13 quarters since.
Exchange Traded Concepts's Harmony Biosciences position peaked at $3.2M in Q2 2026.
75 funds tracked by Wall St. Rank held Harmony Biosciences as of Q3 2026.

Based on Exchange Traded Concepts's 13F filing for Q3 2026, filed 28 Oct 2026.